Oramed pharmaceuticals: coo & cbo Hexter Joshua sold 30,000 shares

What happened

• Hexter Joshua, coo & cbo, sold 30,000 shares in an open market or private sale on Oct 1, 2026. The filing reports a weighted average price of $4.51 and total proceeds of $135,330.

Key details

• Transaction date and price: Oct 1, 2026; weighted average price $4.51 (multiple trades at prices ranging from $4.440 to $4.650, inclusive).
• Transaction code: S (sale).
• Shares owned after the transaction: not reported in this Form 4.
• Footnotes: The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on Mar 30, 2026, and that the reported price is a weighted average with per-share prices in the $4.440–$4.650 range; full breakdown available on request.
• Filing date and timeliness: filed Oct 2, 2026 (reporting period Oct 1, 2026).

Why it may matter

• The filing indicates the sale was executed under a Rule 10b5-1 plan and that shares were sold in multiple transactions at prices within the stated range.
• The filing does not show why the insider traded or why the company acted.